Contrasting roles of Leu356 in the human CCK1 receptor for antagonist SR 27897 and agonist SR 146131 binding
- 1 November 1999
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 383 (3) , 339-346
- https://doi.org/10.1016/s0014-2999(99)00612-3
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extensionPublished by Elsevier ,2003
- Met-195 of the Cholecystokinin-A Receptor Interacts with the Sulfated Tyrosine of Cholecystokinin and Is Crucial for Receptor Transition to High Affinity StateJournal of Biological Chemistry, 1998
- Direct Identification of a Second Distinct Site of Contact between Cholecystokinin and Its ReceptorJournal of Biological Chemistry, 1998
- Direct Identification of a Distinct Site of Interaction between the Carboxyl-terminal Residue of Cholecystokinin and the Type A Cholecystokinin Receptor Using Photoaffinity LabelingJournal of Biological Chemistry, 1997
- His381 of the rat CCKB receptor is essential for CCKB versus CCKA receptor antagonist selectivityEuropean Journal of Pharmacology, 1996
- Identification of Residues Involved in Ligand Binding to the Neurokinin-2 ReceptorBiochemistry, 1995
- A single point mutation increases the affinity of serotonin 5-HT1Dα, 5-HT1Dβ, 5-HT1E and 5-HT1F receptors for β-adrenergic antagonistsNeuropharmacology, 1994
- Molecular Cloning, Functional Expression and Chromosomal Localization of the Human Cholecystokinin Type A ReceptorBiochemical and Biophysical Research Communications, 1993
- Peripheral biological activity of SR 27897: a new potent non-peptide antagonist of CCKA receptorsEuropean Journal of Pharmacology, 1993
- The extracellular domain of the neurokinin-1 receptor is required for high-affinity binding of peptidesBiochemistry, 1992